These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 22765287

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE.
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay.
    Chevrier MC, St-Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G.
    Transfusion; 2007 Oct; 47(10):1794-802. PubMed ID: 17880603
    [Abstract] [Full Text] [Related]

  • 27. Sensitivity comparison of two Food and Drug Administration-licensed, triplex nucleic acid test automated assays for hepatitis B virus DNA detection and associated projections of United States yield.
    Stramer SL, Krysztof DE, Brodsky JP, Fickett TA, Reynolds B, Phikulsod S, Oota S, Lin M, Saldanha J, Kleinman SH.
    Transfusion; 2011 Sep; 51(9):2012-22. PubMed ID: 21896033
    [Abstract] [Full Text] [Related]

  • 28. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?
    Niederhauser C, Mansouri Taleghani B, Graziani M, Stolz M, Tinguely C, Schneider P.
    Swiss Med Wkly; 2008 Mar 08; 138(9-10):134-41. PubMed ID: 18330733
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection?
    Dodd RY, Nguyen ML, Krysztof DE, Notari EP, Stramer SL.
    Transfusion; 2018 Sep 08; 58(9):2166-2170. PubMed ID: 30144082
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E.
    Transfusion; 2007 Jan 08; 47(1):74-9. PubMed ID: 17207233
    [Abstract] [Full Text] [Related]

  • 35. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ.
    Transpl Infect Dis; 2008 Dec 08; 10(6):391-5. PubMed ID: 18665905
    [Abstract] [Full Text] [Related]

  • 36. Reassessment of hepatitis B virus window periods for two transcription-mediated amplification assays using screening data of South African blood donors.
    Vermeulen M, van Drimmelen H, Coleman C, Sykes W, Reddy R, Busch M, Kleinman S, Lelie N.
    Transfusion; 2019 Sep 08; 59(9):2922-2930. PubMed ID: 31265759
    [Abstract] [Full Text] [Related]

  • 37. Use of supplemental anti-HBc testing of donors showing non-discriminating reactive results in multiplex nucleic acid testing.
    Kang JW, Seo JH, Youn KW, Seo YI, Huh K, Choi GR, Min HK, Oh DJ, Jo HJ, Kim JN.
    Vox Sang; 2017 Oct 08; 112(7):622-627. PubMed ID: 28891069
    [Abstract] [Full Text] [Related]

  • 38. Comparison of seven hepatitis B virus (HBV) nucleic acid testing assays in selected samples with discrepant HBV marker results from United States blood donors.
    Enjalbert F, Krysztof DE, Candotti D, Allain JP, Stramer SL.
    Transfusion; 2014 Oct 08; 54(10):2485-95. PubMed ID: 24738835
    [Abstract] [Full Text] [Related]

  • 39. HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA.
    Yoshikawa A, Gotanda Y, Itabashi M, Minegishi K, Kanemitsu K, Nishioka K, Japanese Red Cross NAT Screening Research Group.
    Vox Sang; 2005 Feb 08; 88(2):77-86. PubMed ID: 15720604
    [Abstract] [Full Text] [Related]

  • 40. Molecular characterization of occult hepatitis B cases in Greek blood donors.
    Katsoulidou A, Paraskevis D, Magiorkinis E, Moschidis Z, Haida C, Hatzitheodorou E, Varaklioti A, Karafoulidou A, Hatzitaki M, Kavallierou L, Mouzaki A, Andrioti E, Veneti C, Kaperoni A, Zervou E, Politis C, Hatzakis A.
    J Med Virol; 2009 May 08; 81(5):815-25. PubMed ID: 19319945
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.